60 related articles for article (PubMed ID: 8331496)
1. Preparations of liposomal fluconazole and their in vitro antifungal activity.
Singh M; Singh MP; Maiti SN; Gandhi A; Micetich RG; Atwal H
J Microencapsul; 1993; 10(2):229-36. PubMed ID: 8331496
[TBL] [Abstract][Full Text] [Related]
2. In vitro activity of 2-cyclohexylidenhydrazo-4-phenyl-thiazole compared with those of amphotericin B and fluconazole against clinical isolates of Candida spp. and fluconazole-resistant Candida albicans.
De Logu A; Saddi M; Cardia MC; Borgna R; Sanna C; Saddi B; Maccioni E
J Antimicrob Chemother; 2005 May; 55(5):692-8. PubMed ID: 15772140
[TBL] [Abstract][Full Text] [Related]
3. Susceptibility of several species of Candida and Torulopsis to fluconazole and ketoconazole.
Mallié M; Montès B; Reynes J; Bastide JM
Drugs Exp Clin Res; 1990; 16(10):509-13. PubMed ID: 2100733
[TBL] [Abstract][Full Text] [Related]
4. [In vitro evaluation of the sensitivity to fluconazole of different species of yeasts isolated in pathology].
Regli P; Blancard A; Goudard M; Moulin-Traffort J; Sarzier JM; Quilici M
Pathol Biol (Paris); 1992 May; 40(5):500-6. PubMed ID: 1495834
[TBL] [Abstract][Full Text] [Related]
5. In vitro activity of fluconazole on Candida albicans.
Abecia LC; Arévalo JM; López MJ
Microbiologia; 1996 Dec; 12(4):613-20. PubMed ID: 9018696
[TBL] [Abstract][Full Text] [Related]
6. [CHROMAgar Candida with fluconazole: comparison with microdilution techniques].
Linares MJ; Charriel G; Solís F; Casal M
Enferm Infecc Microbiol Clin; 2003 Nov; 21(9):493-7. PubMed ID: 14572382
[TBL] [Abstract][Full Text] [Related]
7. [The value of the agar dilution method as a screening test for determining the sensitivity of Candida albicans to fluconazole].
Yücesoy M; Marol S
Mikrobiyol Bul; 2002; 36(3-4):317-22. PubMed ID: 12838666
[TBL] [Abstract][Full Text] [Related]
8. [In vitro activity of fluconazole against Candida albicans isolated from blood culture].
Pemán J; Cantón E; Orero A; Ubeda P; Viudes A; Pastor A; Gobernado M
Rev Esp Quimioter; 1998 Dec; 11(4):339-43. PubMed ID: 10336314
[TBL] [Abstract][Full Text] [Related]
9. Carboxylic acid and phosphate ester derivatives of fluconazole: synthesis and antifungal activities.
Nam NH; Sardari S; Selecky M; Parang K
Bioorg Med Chem; 2004 Dec; 12(23):6255-69. PubMed ID: 15519168
[TBL] [Abstract][Full Text] [Related]
10. [In vitro activities of posaconazole, fluconazole, itraconazole, ketoconazole and voriconazole against Candida glabrata].
Blanco MT; Cañadas J; García-Martos P; Marín P; García-Tapia A; Rodríguez J
Rev Esp Quimioter; 2009 Sep; 22(3):139-43. PubMed ID: 19662547
[TBL] [Abstract][Full Text] [Related]
11. National surveillance of species distribution in blood isolates of Candida species in Japan and their susceptibility to six antifungal agents including voriconazole and micafungin.
Takakura S; Fujihara N; Saito T; Kudo T; Iinuma Y; Ichiyama S
J Antimicrob Chemother; 2004 Feb; 53(2):283-9. PubMed ID: 14688039
[TBL] [Abstract][Full Text] [Related]
12. [Biofilm production and antifungal susceptibility patterns of Candida species].
Yücesoy M; Karaman M
Mikrobiyol Bul; 2004; 38(1-2):91-8. PubMed ID: 15293907
[TBL] [Abstract][Full Text] [Related]
13. Effect of chemosensitizers on minimum inhibitory concentrations of fluconazole in Candida albicans.
Bulatova NR; Darwish RM
Med Princ Pract; 2008; 17(2):117-21. PubMed ID: 18287794
[TBL] [Abstract][Full Text] [Related]
14. CHROMagar Candida medium for direct susceptibility testing of yeast from blood cultures.
Tan GL; Peterson EM
J Clin Microbiol; 2005 Apr; 43(4):1727-31. PubMed ID: 15814992
[TBL] [Abstract][Full Text] [Related]
15. Activities of micafungin against 315 invasive clinical isolates of fluconazole-resistant Candida spp.
Messer SA; Diekema DJ; Boyken L; Tendolkar S; Hollis RJ; Pfaller MA
J Clin Microbiol; 2006 Feb; 44(2):324-6. PubMed ID: 16455878
[TBL] [Abstract][Full Text] [Related]
16. In vitro activities of isavuconazole and other antifungal agents against Candida bloodstream isolates.
Seifert H; Aurbach U; Stefanik D; Cornely O
Antimicrob Agents Chemother; 2007 May; 51(5):1818-21. PubMed ID: 17307977
[TBL] [Abstract][Full Text] [Related]
17. [Screening of Candida albicans fluconazole--resistant mutation strains].
Wang W; Zhang B; Wang X; Liu Y; Wang D
Wei Sheng Wu Xue Bao; 1997 Jun; 37(3):212-6. PubMed ID: 9863212
[TBL] [Abstract][Full Text] [Related]
18. Rapid identification of fluconazole resistance using Chromagar Candida.
Verghese SL; Padmaja P; Sutha P; Mathew T; John ES
Indian J Pathol Microbiol; 2000 Jul; 43(3):343-6. PubMed ID: 11218683
[TBL] [Abstract][Full Text] [Related]
19. Identification of Candida species isolated from patients in intensive care unit and in vitro susceptibility to fluconazole for a 3-year period.
Comert F; Kulah C; Aktas E; Eroglu O; Ozlu N
Mycoses; 2007 Jan; 50(1):52-7. PubMed ID: 17302749
[TBL] [Abstract][Full Text] [Related]
20. The efficiency of the benzothiazole APB, the echinocandin micafungin, and amphotericin B in fluconazole-resistant Candida albicans and Candida dubliniensis.
Melkusová S; Bujdáková H; Volleková A; Myoken Y; Mikami Y
Pharmazie; 2004 Jul; 59(7):573-4. PubMed ID: 15296100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
